{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,18]],"date-time":"2025-06-18T12:02:54Z","timestamp":1750248174783},"reference-count":158,"publisher":"Elsevier","isbn-type":[{"value":"9780123756725","type":"print"}],"license":[{"start":{"date-parts":[[2011,1,1]],"date-time":"2011-01-01T00:00:00Z","timestamp":1293840000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011]]},"DOI":"10.1016\/b978-0-12-375672-5.10011-8","type":"book-chapter","created":{"date-parts":[[2010,9,3]],"date-time":"2010-09-03T09:11:40Z","timestamp":1283505100000},"page":"385-426","source":"Crossref","is-referenced-by-count":4,"title":["Biomarkers in Preeclampsia"],"prefix":"10.1016","author":[{"given":"Ana Sofia","family":"Cerdeira","sequence":"first","affiliation":[]},{"given":"S. Ananth","family":"Karumanchi","sequence":"additional","affiliation":[]}],"member":"78","reference":[{"key":"10.1016\/B978-0-12-375672-5.10011-8_bib1","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1053\/j.semperi.2009.02.010","article-title":"The global impact of pre-eclampsia and eclampsia","volume":"33","author":"Duley","year":"2009","journal-title":"Semin Perinatol"},{"issue":"9461","key":"10.1016\/B978-0-12-375672-5.10011-8_bib2","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/S0140-6736(05)71003-5","article-title":"Pre-eclampsia","volume":"365","author":"Sibai","year":"2005","journal-title":"Lancet"},{"issue":"9608","key":"10.1016\/B978-0-12-375672-5.10011-8_bib3","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/S0140-6736(08)60136-1","article-title":"An overview of mortality and sequelae of preterm birth from infancy to adulthood","volume":"371","author":"Saigal","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/B978-0-12-375672-5.10011-8_bib4","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.1056\/NEJMoa042275","article-title":"Premature birth and later insulin resistance","volume":"351","author":"Hofman","year":"2004","journal-title":"N Engl J Med"},{"issue":"9221","key":"10.1016\/B978-0-12-375672-5.10011-8_bib5","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1016\/S0140-6736(00)02384-9","article-title":"Adult cardiovascular risk factors in premature babies","volume":"355","author":"Irving","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/B978-0-12-375672-5.10011-8_bib6","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1056\/NEJMoa067187","article-title":"Glucose regulation in young adults with very low birth weight","volume":"356","author":"Hovi","year":"2007","journal-title":"N Engl J Med"},{"issue":"7491","key":"10.1016\/B978-0-12-375672-5.10011-8_bib7","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1136\/bmj.38380.674340.E0","article-title":"Risk factors for pre-eclampsia at antenatal booking: systematic review of controlled studies","volume":"330","author":"Duckitt","year":"2005","journal-title":"BMJ"},{"key":"10.1016\/B978-0-12-375672-5.10011-8_bib8","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1056\/NEJMoa011379","article-title":"The interval between pregnancies and the risk of preeclampsia","volume":"346","author":"Skjaerven","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/B978-0-12-375672-5.10011-8_bib9","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1111\/j.1479-828X.1995.tb01879.x","article-title":"An instructive case of abdominal pregnancy","volume":"35","author":"Shembrey","year":"1995","journal-title":"Aust N Z J Obstet Gynaecol"},{"key":"10.1016\/B978-0-12-375672-5.10011-8_bib10","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/0029-7844(95)00268-V","article-title":"The changing clinical presentation of complete molar pregnancy","volume":"86","author":"Soto-Wright","year":"1995","journal-title":"Obstet Gynecol"},{"key":"10.1016\/B978-0-12-375672-5.10011-8_bib11","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1055\/s-2007-976548","article-title":"Late postpartum eclampsia: report of two cases managed by uterine curettage and review of the literature","volume":"24","author":"Matsuo","year":"2007","journal-title":"Am J Perinatol"},{"key":"10.1016\/B978-0-12-375672-5.10011-8_bib12","first-page":"291","article-title":"The relation between hydatid moles, relative ischemia of the gravid uterus and the placental origin of eclampsia","volume":"37","author":"Page","year":"1939","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/B978-0-12-375672-5.10011-8_bib13","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1016\/0002-9378(89)90665-0","article-title":"Preeclampsia: an endothelial cell disorder","volume":"161","author":"Roberts","year":"1989","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/B978-0-12-375672-5.10011-8_bib14","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1056\/NEJMoa031884","article-title":"Circulating angiogenic factors and the risk of preeclampsia","volume":"350","author":"Levine","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/B978-0-12-375672-5.10011-8_bib15","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1056\/NEJMoa055352","article-title":"Soluble endoglin and other circulating antiangiogenic factors in preeclampsia","volume":"355","author":"Levine","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/B978-0-12-375672-5.10011-8_bib16","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1038\/nm1429","article-title":"Soluble endoglin contributes to the pathogenesis of preeclampsia","volume":"12","author":"Venkatesha","year":"2006","journal-title":"Nat Med"},{"key":"10.1016\/B978-0-12-375672-5.10011-8_bib17","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1038\/nm0808-810","article-title":"Putting pressure on pre-eclampsia","volume":"14","author":"Parikh","year":"2008","journal-title":"Nat Med"},{"key":"10.1016\/B978-0-12-375672-5.10011-8_bib18","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0002-9378(16)32330-4","article-title":"Syndrome of hemolysis, elevated liver enzymes, and low platelet count: a severe consequence of hypertension in pregnancy","volume":"142","author":"Weinstein","year":"1982","journal-title":"Am J Obstet Gynecol"},{"issue":"5 Pt 1","key":"10.1016\/B978-0-12-375672-5.10011-8_bib19","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1097\/01.AOG.0000126245.35811.2a","article-title":"Diagnosis, controversies, and management of the syndrome of hemolysis, elevated liver enzymes, and low platelet count","volume":"103","author":"Sibai","year":"2004","journal-title":"Obstet Gynecol"},{"key":"10.1016\/B978-0-12-375672-5.10011-8_bib20","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1067\/mob.2000.107928","article-title":"Report of the National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy","volume":"183","year":"2000","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/B978-0-12-375672-5.10011-8_bib21","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1097\/01.AOG.0000152351.13671.99","article-title":"Diagnosis, prevention, and management of eclampsia","volume":"105","author":"Sibai","year":"2005","journal-title":"Obstet Gynecol"},{"key":"10.1016\/B978-0-12-375672-5.10011-8_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2008.07.048","article-title":"Diagnosis and management of atypical preeclampsia-eclampsia","volume":"200","author":"Sibai","year":"2009","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/B978-0-12-375672-5.10011-8_bib23","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1111\/j.1751-7176.2009.00085.x","article-title":"ASH position paper: hypertension in pregnancy","volume":"11","author":"Lindheimer","year":"2009","journal-title":"J Clin Hypertens (Greenwich)"},{"key":"10.1016\/B978-0-12-375672-5.10011-8_bib24","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/1741-7015-7-10","article-title":"Estimation of proteinuria as a predictor of complications of pre-eclampsia: a systematic review","volume":"7","author":"Thangaratinam","year":"2009","journal-title":"BMC Med"},{"key":"10.1016\/B978-0-12-375672-5.10011-8_bib25","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.1681\/ASN.2007020255","article-title":"The glomerular injury of preeclampsia","volume":"18","author":"Stillman","year":"2007","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/B978-0-12-375672-5.10011-8_bib26","doi-asserted-by":"crossref","first-page":"c72","DOI":"10.1159\/000101801","article-title":"Pre-eclampsia: clinical manifestations and molecular mechanisms","volume":"106","author":"Baumwell","year":"2007","journal-title":"Nephron Clin Pract"},{"key":"10.1016\/B978-0-12-375672-5.10011-8_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2007.02.007","article-title":"Urinary podocyte excretion as a marker for preeclampsia","volume":"196","author":"Garovic","year":"2007","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/B978-0-12-375672-5.10011-8_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2009.06.060","article-title":"Health of children born to mothers who had preeclampsia: a population-based cohort study","volume":"201","author":"Wu","year":"2009","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/B978-0-12-375672-5.10011-8_bib29","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1002\/uog.7450","article-title":"Does pre-eclampsia influence fetal cardiovascular function in early-onset intrauterine growth restriction?","volume":"34","author":"Crispi","year":"2009","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/B978-0-12-375672-5.10011-8_bib30","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1203\/01.pdr.0000196734.54473.e3","article-title":"Maternal preeclampsia predicts elevated blood pressure in 12-year-old children: evaluation by ambulatory blood pressure monitoring","volume":"59","author":"Tenhola","year":"2006","journal-title":"Pediatr Res"},{"key":"10.1016\/B978-0-12-375672-5.10011-8_bib31","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1111\/j.1471-0528.1991.tb15339.x","article-title":"Pre-eclampsia and offspring\u2019s blood pressure, cognitive ability and physical development at 17-years-of-age","volume":"98","author":"Seidman","year":"1991","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1016\/B978-0-12-375672-5.10011-8_bib32","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1161\/STROKEAHA.108.538025","article-title":"Pre-eclampsia is associated with increased risk of stroke in the adult offspring: the Helsinki birth cohort study","volume":"40","author":"Kajantie","year":"2009","journal-title":"Stroke"},{"key":"10.1016\/B978-0-12-375672-5.10011-8_bib33","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1056\/NEJMoa0706790","article-title":"Preeclampsia and the risk of end-stage renal disease","volume":"359","author":"Vikse","year":"2008","journal-title":"N Engl J Med"},{"issue":"7627","key":"10.1016\/B978-0-12-375672-5.10011-8_bib34","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1136\/bmj.39335.385301.BE","article-title":"Pre-eclampsia and risk of cardiovascular disease and cancer in later life: systematic review and meta-analysis","volume":"335","author":"Bellamy","year":"2007","journal-title":"BMJ"},{"issue":"7323","key":"10.1016\/B978-0-12-375672-5.10011-8_bib35","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1136\/bmj.323.7323.1213","article-title":"Long term mortality of mothers and fathers after pre-eclampsia: population based cohort study","volume":"323","author":"Irgens","year":"2001","journal-title":"BMJ"},{"key":"10.1016\/B978-0-12-375672-5.10011-8_bib36","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.ejogrb.2008.03.004","article-title":"Severe, very early onset preeclampsia: subsequent pregnancies and future parental cardiovascular health","volume":"140","author":"Gaugler-Senden","year":"2008","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/B978-0-12-375672-5.10011-8_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2009.06.033","article-title":"Long-term maternal and subsequent pregnancy outcomes 5 years after hemolysis, elevated liver enzymes, and low platelets (HELLP) syndrome","volume":"201","author":"Habli","year":"2009","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/B978-0-12-375672-5.10011-8_bib38","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1111\/j.1471-0528.1995.tb10874.x","article-title":"Blood pressure and renal function seven years after pregnancy complicated by hypertension","volume":"102","author":"Nisell","year":"1995","journal-title":"Br J Obstet Gynaecol"},{"issue":"9250","key":"10.1016\/B978-0-12-375672-5.10011-8_bib39","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S0140-6736(00)03552-2","article-title":"Blood-pressure measurement and classification in pregnancy","volume":"357","author":"Higgins","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/B978-0-12-375672-5.10011-8_bib40","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1081\/PRG-200059849","article-title":"The accuracy of urine dipsticks as a screening test for proteinuria in hypertensive disorders of pregnancy","volume":"24","author":"Gangaram","year":"2005","journal-title":"Hypertens Pregnancy"},{"key":"10.1016\/B978-0-12-375672-5.10011-8_bib41","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1097\/01.AOG.0000134788.01016.2a","article-title":"Random urine protein\u2013creatinine ratio to predict proteinuria in new-onset mild hypertension in late pregnancy","volume":"104","author":"Al","year":"2004","journal-title":"Obstet Gynecol"},{"issue":"7651","key":"10.1016\/B978-0-12-375672-5.10011-8_bib42","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1136\/bmj.39532.543947.BE","article-title":"Diagnostic accuracy of urinary spot protein: creatinine ratio for proteinuria in hypertensive pregnant women: systematic review","volume":"336","author":"Cote","year":"2008","journal-title":"BMJ"},{"key":"10.1016\/B978-0-12-375672-5.10011-8_bib43","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1097\/01.AOG.0000147599.47713.5d","article-title":"World Health Organization systematic review of screening tests for preeclampsia","volume":"104","author":"Conde-Agudelo","year":"2004","journal-title":"Obstet Gynecol"},{"key":"10.1016\/B978-0-12-375672-5.10011-8_bib44","series-title":"Chesley\u2019s Hypertensive Disorders in Pregnancy","first-page":"189","article-title":"Tests to predict preeclampsia","author":"Conde-Agudelo","year":"2009"},{"key":"10.1016\/B978-0-12-375672-5.10011-8_bib45","doi-asserted-by":"crossref","first-page":"2348","DOI":"10.1210\/jc.2002-021942","article-title":"Elevated serum soluble vascular endothelial growth factor receptor 1 (sVEGFR-1) levels in women with preeclampsia","volume":"88","author":"Koga","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/B978-0-12-375672-5.10011-8_bib46","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1172\/JCI17189","article-title":"Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia","volume":"111","author":"Maynard","year":"2003","journal-title":"J Clin Invest"},{"key":"10.1016\/B978-0-12-375672-5.10011-8_bib47","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1067\/mob.2001.113129","article-title":"Low maternal serum levels of placenta growth factor as an antecedent of clinical preeclampsia","volume":"184","author":"Tidwell","year":"2001","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/B978-0-12-375672-5.10011-8_bib48","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1016\/S0029-7844(03)00338-7","article-title":"Second-trimester maternal serum placental growth factor and vascular endothelial growth factor for predicting severe, early-onset preeclampsia","volume":"101","author":"Polliotti","year":"2003","journal-title":"Obstet Gynecol"},{"key":"10.1016\/B978-0-12-375672-5.10011-8_bib49","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1210\/jc.2003-031244","article-title":"First trimester placental growth factor and soluble fms-like tyrosine kinase 1 and risk for preeclampsia","volume":"89","author":"Thadhani","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/B978-0-12-375672-5.10011-8_bib50","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2006.11.002","article-title":"Identification of patients at risk for early onset and\/or severe preeclampsia with the use of uterine artery Doppler velocimetry and placental growth factor","volume":"196","author":"Espinoza","year":"2007","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/B978-0-12-375672-5.10011-8_bib51","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1373\/clinchem.2004.036715","article-title":"Maternal serum sFlt1 concentration is an early and reliable predictive marker of preeclampsia","volume":"50","author":"Hertig","year":"2004","journal-title":"Clin Chem"},{"key":"10.1016\/B978-0-12-375672-5.10011-8_bib52","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1080\/14767050400028816","article-title":"Plasma soluble vascular endothelial growth factor receptor-1 concentration is elevated prior to the clinical diagnosis of pre-eclampsia","volume":"17","author":"Chaiworapongsa","year":"2005","journal-title":"J Matern Fetal Neonatal Med"},{"key":"10.1016\/B978-0-12-375672-5.10011-8_bib53","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1002\/pd.2217","article-title":"Soluble endoglin and transforming growth factor-beta1 in women who subsequently developed preeclampsia","volume":"29","author":"Lim","year":"2009","journal-title":"Prenat Diagn"},{"key":"10.1016\/B978-0-12-375672-5.10011-8_bib54","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1097\/AOG.0b013e3181719b7a","article-title":"Effective prediction of preeclampsia by a combined ratio of angiogenesis-related factors","volume":"111","author":"Lim","year":"2008","journal-title":"Obstet Gynecol"},{"key":"10.1016\/B978-0-12-375672-5.10011-8_bib55","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1161\/01.HYP.0000258404.21552.a3","article-title":"Predictive value of maternal angiogenic factors in second trimester pregnancies with abnormal uterine perfusion","volume":"49","author":"Stepan","year":"2007","journal-title":"Hypertension"},{"key":"10.1016\/B978-0-12-375672-5.10011-8_bib56","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2007.08.052","article-title":"Circulatory soluble endoglin and its predictive value for preeclampsia in second-trimester pregnancies with abnormal uterine perfusion","volume":"198","author":"Stepan","year":"2008","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/B978-0-12-375672-5.10011-8_bib57","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.ijgo.2008.02.016","article-title":"Angiogenic factors for the prediction of pre-eclampsia in women with abnormal midtrimester uterine artery Doppler velocimetry","volume":"102","author":"Diab","year":"2008","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1016\/B978-0-12-375672-5.10011-8_bib58","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1080\/00016340802253759","article-title":"Endoglin, PlGF and sFlt-1 as markers for predicting pre-eclampsia","volume":"87","author":"De Vivo","year":"2008","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/B978-0-12-375672-5.10011-8_bib59","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.3109\/14767050902994754","article-title":"A prospective cohort study of the value of maternal plasma concentrations of angiogenic and anti-angiogenic factors in early pregnancy and midtrimester in the identification of patients destined to develop preeclampsia","volume":"22","author":"Kusanovic","year":"2009","journal-title":"J Matern Fetal Neonatal Med"},{"key":"10.1016\/B978-0-12-375672-5.10011-8_bib60","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1161\/HYPERTENSIONAHA.107.087700","article-title":"Sequential changes in antiangiogenic factors in early pregnancy and risk of developing preeclampsia","volume":"50","author":"Rana","year":"2007","journal-title":"Hypertension"},{"key":"10.1016\/B978-0-12-375672-5.10011-8_bib61","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2006.10.909","article-title":"Changes in circulating level of angiogenic factors from the first to second trimester as predictors of preeclampsia","volume":"196","author":"Vatten","year":"2007","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/B978-0-12-375672-5.10011-8_bib62","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1080\/14767050802034545","article-title":"The change in concentrations of angiogenic and anti-angiogenic factors in maternal plasma between the first and second trimesters in risk assessment for the subsequent development of preeclampsia and small-for-gestational age","volume":"21","author":"Erez","year":"2008","journal-title":"J Matern Fetal Neonatal Med"},{"key":"10.1016\/B978-0-12-375672-5.10011-8_bib63","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2007.06.030","article-title":"Angiogenic factors for the prediction of preeclampsia in high-risk women","volume":"197","author":"Moore Simas","year":"2007","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/B978-0-12-375672-5.10011-8_bib64","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2008.06.071","article-title":"Serum inhibin A and angiogenic factor levels in pregnancies with previous preeclampsia and\/or chronic hypertension: are they useful markers for prediction of subsequent preeclampsia?","volume":"199","author":"Sibai","year":"2008","journal-title":"Am J Obstet Gynecol"},{"issue":"2 Pt 2","key":"10.1016\/B978-0-12-375672-5.10011-8_bib65","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1097\/01.AOG.0000248538.03280.cf","article-title":"Cytomegalovirus-induced mirror syndrome associated with elevated levels of circulating antiangiogenic factors","volume":"109","author":"Rana","year":"2007","journal-title":"Obstet Gynecol"},{"key":"10.1016\/B978-0-12-375672-5.10011-8_bib66","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1080\/14767050701413022","article-title":"Unexplained fetal death: another anti-angiogenic state","volume":"20","author":"Espinoza","year":"2007","journal-title":"J Matern Fetal Neonatal Med"},{"key":"10.1016\/B978-0-12-375672-5.10011-8_bib67","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1002\/pd.2065","article-title":"Circulating soluble endoglin and placental abruption","volume":"28","author":"Signore","year":"2008","journal-title":"Prenat Diagn"},{"key":"10.1016\/B978-0-12-375672-5.10011-8_bib68","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1080\/14767050701832833","article-title":"The maternal plasma soluble vascular endothelial growth factor receptor-1 concentration is elevated in SGA and the magnitude of the increase relates to Doppler abnormalities in the maternal and fetal circulation","volume":"21","author":"Chaiworapongsa","year":"2008","journal-title":"J Matern Fetal Neonatal Med"},{"key":"10.1016\/B978-0-12-375672-5.10011-8_bib69","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1067\/mob.2003.111","article-title":"Longitudinal serum concentrations of placental growth factor: evidence for abnormal placental angiogenesis in pathologic pregnancies","volume":"188","author":"Taylor","year":"2003","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/B978-0-12-375672-5.10011-8_bib70","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1080\/14767050701830480","volume":"21","author":"Romero","year":"2008","journal-title":"J Matern Fetal Neonatal Med"},{"key":"10.1016\/B978-0-12-375672-5.10011-8_bib71","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1001\/jama.293.1.77","article-title":"Urinary placental growth factor and risk of preeclampsia","volume":"293","author":"Levine","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/B978-0-12-375672-5.10011-8_bib72","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1038\/sj.ki.5000075","article-title":"Low urinary placental growth factor is a marker of pre-eclampsia","volume":"69","author":"Aggarwal","year":"2006","journal-title":"Kidney Int"},{"key":"10.1016\/B978-0-12-375672-5.10011-8_bib73","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1016\/j.ajog.2004.12.052","article-title":"Urinary angiogenic factors cluster hypertensive disorders and identify women with severe preeclampsia","volume":"192","author":"Buhimschi","year":"2005","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/B978-0-12-375672-5.10011-8_bib74","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1111\/j.1471-0528.2008.02074.x","article-title":"First trimester urinary placental growth factor and development of pre-eclampsia","volume":"116","author":"Savvidou","year":"2009","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1016\/B978-0-12-375672-5.10011-8_bib75","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2007.04.010","article-title":"Diagnostic utility of soluble fms-like tyrosine kinase 1 and soluble endoglin in hypertensive diseases of pregnancy","volume":"197","author":"Salahuddin","year":"2007","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/B978-0-12-375672-5.10011-8_bib76","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2009.07.025","article-title":"Automated assays for sVEGF R1 and PlGF as an aid in the diagnosis of preterm preeclampsia: a prospective clinical study","volume":"202","author":"Sunderji","year":"2010","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/B978-0-12-375672-5.10011-8_bib77","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1053\/j.ajkd.2008.03.011","article-title":"Use of circulating antiangiogenic factors to differentiate other hypertensive disorders from preeclampsia in a pregnant woman on dialysis","volume":"51","author":"Shan","year":"2008","journal-title":"Am J Kidney Dis"},{"issue":"2","key":"10.1016\/B978-0-12-375672-5.10011-8_bib78","doi-asserted-by":"crossref","first-page":"161.e1","DOI":"10.1016\/j.ajog.2009.09.016","article-title":"An automated method for the determination of the sFlt-1\/PIGF ratio in the assessment of preeclampsia","volume":"202","author":"Verlohren","year":"2010","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/B978-0-12-375672-5.10011-8_bib79","first-page":"343","article-title":"Purification and characterization of two new soluble placental tissue proteins (PP13 and PP17)","volume":"4","author":"Bohn","year":"1983","journal-title":"Oncodev Biol Med"},{"key":"10.1016\/B978-0-12-375672-5.10011-8_bib80","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1093\/protein\/14.11.875","article-title":"Homology modelling and molecular dynamics studies of human placental tissue protein 13 (galectin-13)","volume":"14","author":"Visegrady","year":"2001","journal-title":"Protein Eng"},{"key":"10.1016\/B978-0-12-375672-5.10011-8_bib81","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1111\/j.1432-1033.2004.04004.x","article-title":"Functional analyzes of placental protein 13\/galectin-13","volume":"271","author":"Than","year":"2004","journal-title":"Eur J Biochem"},{"key":"10.1016\/B978-0-12-375672-5.10011-8_bib82","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1159\/000151344","article-title":"Longitudinal determination of serum placental protein 13 during development of preeclampsia","volume":"24","author":"Huppertz","year":"2008","journal-title":"Fetal Diagn Ther"},{"key":"10.1016\/B978-0-12-375672-5.10011-8_bib83","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/j.placenta.2003.12.009","article-title":"Placental protein 13 (PP-13): effects on cultured trophoblasts, and its detection in human body fluids in normal and pathological pregnancies","volume":"25","author":"Burger","year":"2004","journal-title":"Placenta"},{"key":"10.1016\/B978-0-12-375672-5.10011-8_bib84","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2007.02.025","article-title":"First-trimester placental protein 13 screening for preeclampsia and intrauterine growth restriction","volume":"197","author":"Chafetz","year":"2007","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/B978-0-12-375672-5.10011-8_bib85","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2008.01.013","article-title":"First-trimester maternal serum PP13 in the risk assessment for preeclampsia","volume":"199","author":"Romero","year":"2008","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/B978-0-12-375672-5.10011-8_bib86","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1002\/uog.3876","article-title":"First-trimester maternal serum PP-13, PAPP-A and second-trimester uterine artery Doppler pulsatility index as markers of pre-eclampsia","volume":"29","author":"Spencer","year":"2007","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/B978-0-12-375672-5.10011-8_bib87","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1111\/j.1471-0528.2008.01902.x","article-title":"Placental protein 13 as an early marker for pre-eclampsia: a prospective longitudinal study","volume":"115","author":"Gonen","year":"2008","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1016\/B978-0-12-375672-5.10011-8_bib88","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1002\/pd.2287","article-title":"First trimester maternal serum placental protein 13 for the prediction of pre-eclampsia in women with a priori high risk","volume":"29","author":"Khalil","year":"2009","journal-title":"Prenat Diagn"},{"key":"10.1016\/B978-0-12-375672-5.10011-8_bib89","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1002\/pd.1664","article-title":"Second-trimester uterine artery Doppler pulsatility index and maternal serum PP13 as markers of pre-eclampsia","volume":"27","author":"Spencer","year":"2007","journal-title":"Prenat Diagn"},{"key":"10.1016\/B978-0-12-375672-5.10011-8_bib90","doi-asserted-by":"crossref","first-page":"3149","DOI":"10.1073\/pnas.96.6.3149","article-title":"The insulin-like growth factor (IGF)-dependent IGF binding protein-4 protease secreted by human fibroblasts is pregnancy-associated plasma protein-A","volume":"96","author":"Lawrence","year":"1999","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/B978-0-12-375672-5.10011-8_bib91","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.1210\/jcem.87.5.8448","article-title":"Identification and regulation of the IGFBP-4 protease and its physiological inhibitor in human trophoblasts and endometrial stroma: evidence for paracrine regulation of IGF-II bioavailability in the placental bed during human implantation","volume":"87","author":"Giudice","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/B978-0-12-375672-5.10011-8_bib92","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1006\/excr.1998.4195","article-title":"Autocrine-paracrine regulation of human trophoblast invasiveness by insulin-like growth factor (IGF)-II and IGF-binding protein (IGFBP)-1","volume":"244","author":"Hamilton","year":"1998","journal-title":"Exp Cell Res"},{"key":"10.1016\/B978-0-12-375672-5.10011-8_bib93","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1002\/pd.2116","article-title":"Low levels of maternal serum PAPP-A in early pregnancy and the risk of adverse outcomes","volume":"28","author":"Spencer","year":"2008","journal-title":"Prenat Diagn"},{"key":"10.1016\/B978-0-12-375672-5.10011-8_bib94","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1002\/pd.1890","article-title":"Low levels of maternal serum PAPP-A in the first trimester and the risk of pre-eclampsia","volume":"28","author":"Spencer","year":"2008","journal-title":"Prenat Diagn"},{"key":"10.1016\/B978-0-12-375672-5.10011-8_bib95","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/1471-2393-8-33","article-title":"Serum screening with Down\u2019s syndrome markers to predict pre-eclampsia and small for gestational age: systematic review and meta-analysis","volume":"8","author":"Morris","year":"2008","journal-title":"BMC Pregnancy Childbirth"},{"key":"10.1016\/B978-0-12-375672-5.10011-8_bib96","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1002\/pd.2339","article-title":"First trimester serum PAPP-A and NGAL in the prediction of late-onset pre-eclampsia","volume":"29","author":"D\u2019Anna","year":"2009","journal-title":"Prenat Diagn"},{"key":"10.1016\/B978-0-12-375672-5.10011-8_bib97","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1016\/S0002-9378(98)70549-6","article-title":"The clinical utility of serum uric acid measurements in hypertensive diseases of pregnancy","volume":"178","author":"Lim","year":"1998","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/B978-0-12-375672-5.10011-8_bib98","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1111\/j.1471-0528.2006.00908.x","article-title":"Accuracy of serum uric acid in predicting complications of pre-eclampsia: a systematic review","volume":"113","author":"Thangaratinam","year":"2006","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1016\/B978-0-12-375672-5.10011-8_bib99","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta12060","article-title":"Methods of prediction and prevention of pre-eclampsia: systematic reviews of accuracy and effectiveness literature with economic modelling","volume":"12","author":"Meads","year":"2008","journal-title":"Health Technol Assess"},{"key":"10.1016\/B978-0-12-375672-5.10011-8_bib100","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1111\/j.1471-0528.1996.tb09767.x","article-title":"Early prediction of pre-eclampsia by measurement of kallikrein and creatinine on a random urine sample","volume":"103","author":"Millar","year":"1996","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1016\/B978-0-12-375672-5.10011-8_bib101","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1111\/j.1471-0528.1996.tb09547.x","article-title":"A comparison of the inactive urinary kallikrein: creatinine ratio and the angiotensin sensitivity test for the prediction of pre-eclampsia","volume":"103","author":"Kyle","year":"1996","journal-title":"Br J Obstet Gynaecol"},{"issue":"7606","key":"10.1016\/B978-0-12-375672-5.10011-8_bib102","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1016\/S0140-6736(69)91642-0","article-title":"Practical and theoretical implications of fetal\u2013maternal lymphocyte transfer","volume":"1","author":"Walknowska","year":"1969","journal-title":"Lancet"},{"issue":"9076","key":"10.1016\/B978-0-12-375672-5.10011-8_bib103","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/S0140-6736(97)02174-0","article-title":"Presence of fetal DNA in maternal plasma and serum","volume":"350","author":"Lo","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/B978-0-12-375672-5.10011-8_bib104","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1111\/j.1749-6632.2001.tb03887.x","article-title":"Circulating fetal RNA in maternal plasma","volume":"945","author":"Poon","year":"2001","journal-title":"Ann NY Acad Sci"},{"key":"10.1016\/B978-0-12-375672-5.10011-8_bib105","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.molmed.2009.09.002","article-title":"Fetal\u2013maternal exchange of multipotent stem\/progenitor cells: microchimerism in diagnosis and disease","volume":"15","author":"Klonisch","year":"2009","journal-title":"Trends Mol Med"},{"key":"10.1016\/B978-0-12-375672-5.10011-8_bib106","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0070-2153(04)61004-0","article-title":"The biology and diagnostic applications of fetal DNA and RNA in maternal plasma","volume":"61","author":"Chiu","year":"2004","journal-title":"Curr Top Dev Biol"},{"key":"10.1016\/B978-0-12-375672-5.10011-8_bib107","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1038\/nrg1982","article-title":"Prenatal diagnosis: progress through plasma nucleic acids","volume":"8","author":"Dennis Lo","year":"2007","journal-title":"Nat Rev Genet"},{"issue":"Pt 2","key":"10.1016\/B978-0-12-375672-5.10011-8_bib108","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1042\/BST0370460","article-title":"The SAFE project: towards non-invasive prenatal diagnosis","volume":"37","author":"Maddocks","year":"2009","journal-title":"Biochem Soc Trans"},{"issue":"5 Pt 1","key":"10.1016\/B978-0-12-375672-5.10011-8_bib109","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/S0029-7844(98)00068-4","article-title":"Disturbed feto-maternal cell traffic in preeclampsia","volume":"91","author":"Holzgreve","year":"1998","journal-title":"Obstet Gynecol"},{"key":"10.1016\/B978-0-12-375672-5.10011-8_bib110","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1067\/mob.2001.108861","article-title":"Elevation in erythroblast count in maternal blood before the onset of preeclampsia","volume":"184","author":"Holzgreve","year":"2001","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/B978-0-12-375672-5.10011-8_bib111","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1093\/humrep\/15.7.1624","article-title":"Increased fetal erythroblasts in women who subsequently develop pre-eclampsia","volume":"15","author":"Al-Mufti","year":"2000","journal-title":"Hum Reprod"},{"key":"10.1016\/B978-0-12-375672-5.10011-8_bib112","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1093\/clinchem\/45.2.184","article-title":"Quantitative abnormalities of fetal DNA in maternal serum in preeclampsia","volume":"45","author":"Lo","year":"1999","journal-title":"Clin Chem"},{"key":"10.1016\/B978-0-12-375672-5.10011-8_bib113","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1081\/PRG-120002911","article-title":"The levels of circulatory cell free fetal DNA in maternal plasma are elevated prior to the onset of preeclampsia","volume":"21","author":"Zhong","year":"2002","journal-title":"Hypertens Pregnancy."},{"key":"10.1016\/B978-0-12-375672-5.10011-8_bib114","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1093\/clinchem\/47.1.137","article-title":"Increased maternal plasma fetal DNA concentrations in women who eventually develop preeclampsia","volume":"47","author":"Leung","year":"2001","journal-title":"Clin Chem"},{"key":"10.1016\/B978-0-12-375672-5.10011-8_bib115","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.ajog.2003.12.019","article-title":"Two-stage elevation of cell-free fetal DNA in maternal sera before onset of preeclampsia","volume":"190","author":"Levine","year":"2004","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/B978-0-12-375672-5.10011-8_bib116","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1002\/pd.1645","article-title":"Free fetal DNA is not increased before 20 weeks in intrauterine growth restriction or pre-eclampsia","volume":"27","author":"Crowley","year":"2007","journal-title":"Prenat Diagn"},{"key":"10.1016\/B978-0-12-375672-5.10011-8_bib117","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.ajog.2004.01.040","article-title":"Increased fetal DNA in the maternal circulation in early pregnancy is associated with an increased risk of preeclampsia","volume":"191","author":"Cotter","year":"2004","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/B978-0-12-375672-5.10011-8_bib118","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1002\/pd.1897","article-title":"Quantitative aberrations of hypermethylated RASSF1A gene sequences in maternal plasma in pre-eclampsia","volume":"27","author":"Tsui","year":"2007","journal-title":"Prenat Diagn"},{"key":"10.1016\/B978-0-12-375672-5.10011-8_bib119","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1111\/j.1471-0528.2004.00499.x","article-title":"Increased fetal RhD gene in the maternal circulation in early pregnancy is associated with an increased risk of pre-eclampsia","volume":"112","author":"Cotter","year":"2005","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1016\/B978-0-12-375672-5.10011-8_bib120","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1002\/pd.973","article-title":"Total cell-free DNA (beta-globin gene) distribution in maternal plasma at the second trimester: a new prospective for preeclampsia screening","volume":"24","author":"Farina","year":"2004","journal-title":"Prenat Diagn"},{"key":"10.1016\/B978-0-12-375672-5.10011-8_bib121","doi-asserted-by":"crossref","first-page":"4748","DOI":"10.1073\/pnas.0637450100","article-title":"mRNA of placental origin is readily detectable in maternal plasma","volume":"100","author":"Ng","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/B978-0-12-375672-5.10011-8_bib122","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2008.11.035","article-title":"Prediction of preeclampsia by analysis of cell-free messenger RNA in maternal plasma","volume":"200","author":"Purwosunu","year":"2009","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/B978-0-12-375672-5.10011-8_bib123","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1503\/cmaj.070430","article-title":"Use of uterine artery Doppler ultrasonography to predict pre-eclampsia and intrauterine growth restriction: a systematic review and bivariable meta-analysis","volume":"178","author":"Cnossen","year":"2008","journal-title":"CMAJ"},{"key":"10.1016\/B978-0-12-375672-5.10011-8_bib124","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1002\/uog.2686","article-title":"A novel approach to first-trimester screening for early pre-eclampsia combining serum PP-13 and Doppler ultrasound","volume":"27","author":"Nicolaides","year":"2006","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"12","key":"10.1016\/B978-0-12-375672-5.10011-8_bib125","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1002\/pd.2375","article-title":"Maternal serum placental protein 13 at 11\u201313 weeks of gestation in preeclampsia","volume":"29","author":"Akolekar","year":"2009","journal-title":"Prenat Diagn"},{"key":"10.1016\/B978-0-12-375672-5.10011-8_bib126","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1002\/pd.1606","article-title":"Comparison of activin A and cell-free fetal DNA levels in maternal plasma from patients at high risk for preeclampsia","volume":"26","author":"Diesch","year":"2006","journal-title":"Prenat Diagn"},{"key":"10.1016\/B978-0-12-375672-5.10011-8_bib127","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2009.05.025","article-title":"First-trimester maternal plasma cell-free fetal DNA and preeclampsia","volume":"201","author":"Sifakis","year":"2009","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/B978-0-12-375672-5.10011-8_bib128","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1161\/HYPERTENSIONAHA.108.127977","article-title":"First-trimester prediction of hypertensive disorders in pregnancy","volume":"53","author":"Poon","year":"2009","journal-title":"Hypertension"},{"key":"10.1016\/B978-0-12-375672-5.10011-8_bib129","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1161\/HYPERTENSIONAHA.109.129379","article-title":"First-trimester prediction of early preeclampsia: a possibility at last!","volume":"53","author":"Levine","year":"2009","journal-title":"Hypertension"},{"key":"10.1016\/B978-0-12-375672-5.10011-8_bib130","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1038\/nm.1903","article-title":"Nanofluidic proteomic assay for serial analysis of oncoprotein activation in clinical specimens","volume":"15","author":"Fan","year":"2009","journal-title":"Nat Med"},{"key":"10.1016\/B978-0-12-375672-5.10011-8_bib131","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1586\/14789450.4.3.401","article-title":"Oncoproteomics: current trends and future perspectives","volume":"4","author":"Cho","year":"2007","journal-title":"Expert Rev Proteomics"},{"key":"10.1016\/B978-0-12-375672-5.10011-8_bib132","doi-asserted-by":"crossref","first-page":"2463","DOI":"10.1056\/NEJMra042342","article-title":"Microarray analysis and tumor classification","volume":"354","author":"Quackenbush","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/B978-0-12-375672-5.10011-8_bib133","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1038\/nrneph.2009.183","article-title":"Application of proteomic analysis to the study of renal diseases","volume":"5","author":"Smith","year":"2009","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/B978-0-12-375672-5.10011-8_bib134","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1056\/NEJMcibr0808487","article-title":"Getting to the heart of proteomics","volume":"360","author":"Ping","year":"2009","journal-title":"N Engl J Med"},{"issue":"5895","key":"10.1016\/B978-0-12-375672-5.10011-8_bib135","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1126\/science.1158554","article-title":"Activation of aldehyde dehydrogenase-2 reduces ischemic damage to the heart","volume":"321","author":"Chen","year":"2008","journal-title":"Science"},{"key":"10.1016\/B978-0-12-375672-5.10011-8_bib136","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1016\/j.jacc.2006.06.063","article-title":"Cardiovascular proteomics: tools to develop novel biomarkers and potential applications","volume":"48","author":"Arab","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/B978-0-12-375672-5.10011-8_bib137","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1002\/pd.1562","article-title":"Quantitative distribution of a panel of circulating mRNA in preeclampsia versus controls","volume":"26","author":"Farina","year":"2006","journal-title":"Prenat Diagn"},{"key":"10.1016\/B978-0-12-375672-5.10011-8_bib138","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/978-1-59745-066-9_22","article-title":"A microarray approach for systematic identification of placental-derived RNA markers in maternal plasma","volume":"444","author":"Tsui","year":"2008","journal-title":"Methods Mol Biol"},{"key":"10.1016\/B978-0-12-375672-5.10011-8_bib139","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1097\/01.AOG.0000286761.11436.67","article-title":"Placenta-derived, cellular messenger RNA expression in the maternal blood of preeclamptic women","volume":"110","author":"Okazaki","year":"2007","journal-title":"Obstet Gynecol"},{"key":"10.1016\/B978-0-12-375672-5.10011-8_bib140","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.placenta.2008.09.015","article-title":"Altered global gene expression in first trimester placentas of women destined to develop preeclampsia","volume":"30","author":"Founds","year":"2009","journal-title":"Placenta"},{"key":"10.1016\/B978-0-12-375672-5.10011-8_bib141","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1002\/pd.2344","article-title":"Gene expression in chorionic villous samples at 11 weeks of gestation in women who develop preeclampsia later in pregnancy: implications for screening","volume":"29","author":"Farina","year":"2009","journal-title":"Prenat Diagn"},{"key":"10.1016\/B978-0-12-375672-5.10011-8_bib142","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.tem.2009.05.001","article-title":"Role of Dicer in female fertility","volume":"20","author":"Luense","year":"2009","journal-title":"Trends Endocrinol Metab"},{"key":"10.1016\/B978-0-12-375672-5.10011-8_bib143","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2007.01.008","article-title":"Distinct subsets of microRNAs are expressed differentially in the human placentas of patients with preeclampsia","volume":"196","author":"Pineles","year":"2007","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/B978-0-12-375672-5.10011-8_bib144","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2008.12.045","article-title":"Differential expression profile of microRNAs in human placentas from preeclamptic pregnancies vs normal pregnancies","volume":"200","author":"Zhu","year":"2009","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/B978-0-12-375672-5.10011-8_bib145","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1095\/biolreprod.108.075481","article-title":"Human villous trophoblasts express and secrete placenta-specific microRNAs into maternal circulation via exosomes","volume":"81","author":"Luo","year":"2009","journal-title":"Biol Reprod"},{"key":"10.1016\/B978-0-12-375672-5.10011-8_bib146","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1373\/clinchem.2007.097972","article-title":"Detection and characterization of placental microRNAs in maternal plasma","volume":"54","author":"Chim","year":"2008","journal-title":"Clin Chem"},{"key":"10.1016\/B978-0-12-375672-5.10011-8_bib147","doi-asserted-by":"crossref","first-page":"2929","DOI":"10.1002\/pmic.200800625","article-title":"A proteomic approach identifies early pregnancy biomarkers for preeclampsia: novel linkages between a predisposition to preeclampsia and cardiovascular disease","volume":"9","author":"Blumenstein","year":"2009","journal-title":"Proteomics"},{"key":"10.1016\/B978-0-12-375672-5.10011-8_bib148","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2008.07.006","article-title":"Proteomic profiling of urine identifies specific fragments of SERPINA1 and albumin as biomarkers of preeclampsia","volume":"199","author":"Buhimschi","year":"2008","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/B978-0-12-375672-5.10011-8_bib149","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.placenta.2008.05.002","article-title":"Analysis of the metabolic footprint and tissue metabolome of placental villous explants cultured at different oxygen tensions reveals novel redox biomarkers","volume":"29","author":"Heazell","year":"2008","journal-title":"Placenta"},{"key":"10.1016\/B978-0-12-375672-5.10011-8_bib150","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1016\/j.placenta.2009.08.008","article-title":"Changes in the metabolic footprint of placental explant-conditioned culture medium identifies metabolic disturbances related to hypoxia and pre-eclampsia","volume":"30","author":"Dunn","year":"2009","journal-title":"Placenta"},{"key":"10.1016\/B978-0-12-375672-5.10011-8_bib151","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1177\/1933719108316908","article-title":"Detection and identification of novel metabolomic biomarkers in preeclampsia","volume":"15","author":"Kenny","year":"2008","journal-title":"Reprod Sci"},{"key":"10.1016\/B978-0-12-375672-5.10011-8_bib152","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/s11306-005-0003-1","article-title":"Novel biomarkers for pre-eclampsia detected using metabolomics and machine learning","volume":"1","author":"Kenny","year":"2005","journal-title":"Metabolomics"},{"key":"10.1016\/B978-0-12-375672-5.10011-8_bib153","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.placenta.2009.01.012","article-title":"Differential placental gene expression in severe preeclampsia","volume":"30","author":"Sitras","year":"2009","journal-title":"Placenta"},{"key":"10.1016\/B978-0-12-375672-5.10011-8_bib154","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.placenta.2006.05.010","article-title":"Microarray analysis of differentially expressed fetal genes in placental tissue derived from early and late onset severe pre-eclampsia","volume":"28","author":"Nishizawa","year":"2007","journal-title":"Placenta"},{"key":"10.1016\/B978-0-12-375672-5.10011-8_bib155","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.aca.2008.09.015","article-title":"Analysis of expression and comparative profile of normal placental tissue proteins and those in preeclampsia patients using proteomic approaches","volume":"629","author":"Jin","year":"2008","journal-title":"Anal Chim Acta"},{"key":"10.1016\/B978-0-12-375672-5.10011-8_bib156","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1177\/1933719108316909","article-title":"Identification of proteomic biomarkers of preeclampsia in amniotic fluid using SELDI-TOF mass spectrometry","volume":"15","author":"Park","year":"2008","journal-title":"Reprod Sci"},{"key":"10.1016\/B978-0-12-375672-5.10011-8_bib157","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1002\/pmic.200300565","article-title":"Proteome analysis reveals elevated serum levels of clusterin in patients with preeclampsia","volume":"4","author":"Watanabe","year":"2004","journal-title":"Proteomics"},{"key":"10.1016\/B978-0-12-375672-5.10011-8_bib158","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1152\/physiol.00043.2008","article-title":"Preeclampsia: the role of angiogenic factors in its pathogenesis","volume":"24","author":"Wang","year":"2009","journal-title":"Physiology (Bethesda)"}],"container-title":["Biomarkers of Kidney Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:B9780123756725100118?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:B9780123756725100118?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,6,11]],"date-time":"2020-06-11T05:58:45Z","timestamp":1591855125000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/B9780123756725100118"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011]]},"ISBN":["9780123756725"],"references-count":158,"URL":"https:\/\/doi.org\/10.1016\/b978-0-12-375672-5.10011-8","relation":{},"subject":[],"published":{"date-parts":[[2011]]}}}